Does pT2b prostate carcinoma exist? Critical appraisal of the 2002 TNM classification of prostate carcinoma

Lori E. Eichelberger, Liang Cheng

Research output: Contribution to journalArticle

68 Citations (Scopus)

Abstract

BACKGROUND. Clinicopathologic staging of prostate adenocarcinoma provides a method for assessing the extent of tumor and predicting patient prognosis. The American Joint Committee on Cancer (AJCC) TNM staging system has undergone recent revisions for T2 prostate tumors. T2 tumors currently are subclassified as T2a (less than one-half of one lobe involvement), T2b (greater than one-half of one lobe involvement), and T2c (bilateral involvement). Despite general acceptance of the system, controversy and uncertainty still exist with regard to the application of the TNM staging system, particularly the use of the T2 staging subclassification. METHODS. The study population was comprised of 369 patients with prostate carcinoma who were treated with radical retropubic prostatectomy. Radical prostatectomy specimens were evaluated histologically by complete embedding and whole-mount processing. Tumor specimens were staged initially using the 1998 AJCC TNM system and then reevaluated according to the 2002 TNM staging guidelines. RESULTS. The weights of the prostate specimens ranged from 14-149 g (median, 38 g). Prostate tumor specimens were multifocal in 312 patients (85%). The majority of the specimens were classified pathologically as T2 (n = 276 [75%]). Using the 2002 TNM staging criteria, 54 of the tumor specimens (15%) were classified as pT2a, 222 (60%) were pT2c, 75 (20%) were pT3a, and 18 (5%) were pT3b. No pathologic T2b tumor specimens were identified. CONCLUSIONS. Taking into consideration the average weight of the prostate specimens (38 g), as well as the predominance of tumor multifocality, it would be unusual to identify tumors involving greater than one-half of 1 lobe (approximately an 8-cm3 tumor) without involving the other lobe. The authors question the existence of a true pT2b tumor.

Original languageEnglish
Pages (from-to)2573-2576
Number of pages4
JournalCancer
Volume100
Issue number12
DOIs
StatePublished - Jun 15 2004

Fingerprint

Neoplasm Staging
Prostate
Carcinoma
Neoplasms
Prostatectomy
Weights and Measures
Uncertainty
Adenocarcinoma
Guidelines

Keywords

  • Classification
  • Neoplasm
  • Prostate
  • Prostatectomy
  • Tumor TNM staging

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Does pT2b prostate carcinoma exist? Critical appraisal of the 2002 TNM classification of prostate carcinoma. / Eichelberger, Lori E.; Cheng, Liang.

In: Cancer, Vol. 100, No. 12, 15.06.2004, p. 2573-2576.

Research output: Contribution to journalArticle

@article{e36efaec60d447eb993caec425e4f345,
title = "Does pT2b prostate carcinoma exist? Critical appraisal of the 2002 TNM classification of prostate carcinoma",
abstract = "BACKGROUND. Clinicopathologic staging of prostate adenocarcinoma provides a method for assessing the extent of tumor and predicting patient prognosis. The American Joint Committee on Cancer (AJCC) TNM staging system has undergone recent revisions for T2 prostate tumors. T2 tumors currently are subclassified as T2a (less than one-half of one lobe involvement), T2b (greater than one-half of one lobe involvement), and T2c (bilateral involvement). Despite general acceptance of the system, controversy and uncertainty still exist with regard to the application of the TNM staging system, particularly the use of the T2 staging subclassification. METHODS. The study population was comprised of 369 patients with prostate carcinoma who were treated with radical retropubic prostatectomy. Radical prostatectomy specimens were evaluated histologically by complete embedding and whole-mount processing. Tumor specimens were staged initially using the 1998 AJCC TNM system and then reevaluated according to the 2002 TNM staging guidelines. RESULTS. The weights of the prostate specimens ranged from 14-149 g (median, 38 g). Prostate tumor specimens were multifocal in 312 patients (85{\%}). The majority of the specimens were classified pathologically as T2 (n = 276 [75{\%}]). Using the 2002 TNM staging criteria, 54 of the tumor specimens (15{\%}) were classified as pT2a, 222 (60{\%}) were pT2c, 75 (20{\%}) were pT3a, and 18 (5{\%}) were pT3b. No pathologic T2b tumor specimens were identified. CONCLUSIONS. Taking into consideration the average weight of the prostate specimens (38 g), as well as the predominance of tumor multifocality, it would be unusual to identify tumors involving greater than one-half of 1 lobe (approximately an 8-cm3 tumor) without involving the other lobe. The authors question the existence of a true pT2b tumor.",
keywords = "Classification, Neoplasm, Prostate, Prostatectomy, Tumor TNM staging",
author = "Eichelberger, {Lori E.} and Liang Cheng",
year = "2004",
month = "6",
day = "15",
doi = "10.1002/cncr.20305",
language = "English",
volume = "100",
pages = "2573--2576",
journal = "Cancer",
issn = "0008-543X",
publisher = "John Wiley and Sons Inc.",
number = "12",

}

TY - JOUR

T1 - Does pT2b prostate carcinoma exist? Critical appraisal of the 2002 TNM classification of prostate carcinoma

AU - Eichelberger, Lori E.

AU - Cheng, Liang

PY - 2004/6/15

Y1 - 2004/6/15

N2 - BACKGROUND. Clinicopathologic staging of prostate adenocarcinoma provides a method for assessing the extent of tumor and predicting patient prognosis. The American Joint Committee on Cancer (AJCC) TNM staging system has undergone recent revisions for T2 prostate tumors. T2 tumors currently are subclassified as T2a (less than one-half of one lobe involvement), T2b (greater than one-half of one lobe involvement), and T2c (bilateral involvement). Despite general acceptance of the system, controversy and uncertainty still exist with regard to the application of the TNM staging system, particularly the use of the T2 staging subclassification. METHODS. The study population was comprised of 369 patients with prostate carcinoma who were treated with radical retropubic prostatectomy. Radical prostatectomy specimens were evaluated histologically by complete embedding and whole-mount processing. Tumor specimens were staged initially using the 1998 AJCC TNM system and then reevaluated according to the 2002 TNM staging guidelines. RESULTS. The weights of the prostate specimens ranged from 14-149 g (median, 38 g). Prostate tumor specimens were multifocal in 312 patients (85%). The majority of the specimens were classified pathologically as T2 (n = 276 [75%]). Using the 2002 TNM staging criteria, 54 of the tumor specimens (15%) were classified as pT2a, 222 (60%) were pT2c, 75 (20%) were pT3a, and 18 (5%) were pT3b. No pathologic T2b tumor specimens were identified. CONCLUSIONS. Taking into consideration the average weight of the prostate specimens (38 g), as well as the predominance of tumor multifocality, it would be unusual to identify tumors involving greater than one-half of 1 lobe (approximately an 8-cm3 tumor) without involving the other lobe. The authors question the existence of a true pT2b tumor.

AB - BACKGROUND. Clinicopathologic staging of prostate adenocarcinoma provides a method for assessing the extent of tumor and predicting patient prognosis. The American Joint Committee on Cancer (AJCC) TNM staging system has undergone recent revisions for T2 prostate tumors. T2 tumors currently are subclassified as T2a (less than one-half of one lobe involvement), T2b (greater than one-half of one lobe involvement), and T2c (bilateral involvement). Despite general acceptance of the system, controversy and uncertainty still exist with regard to the application of the TNM staging system, particularly the use of the T2 staging subclassification. METHODS. The study population was comprised of 369 patients with prostate carcinoma who were treated with radical retropubic prostatectomy. Radical prostatectomy specimens were evaluated histologically by complete embedding and whole-mount processing. Tumor specimens were staged initially using the 1998 AJCC TNM system and then reevaluated according to the 2002 TNM staging guidelines. RESULTS. The weights of the prostate specimens ranged from 14-149 g (median, 38 g). Prostate tumor specimens were multifocal in 312 patients (85%). The majority of the specimens were classified pathologically as T2 (n = 276 [75%]). Using the 2002 TNM staging criteria, 54 of the tumor specimens (15%) were classified as pT2a, 222 (60%) were pT2c, 75 (20%) were pT3a, and 18 (5%) were pT3b. No pathologic T2b tumor specimens were identified. CONCLUSIONS. Taking into consideration the average weight of the prostate specimens (38 g), as well as the predominance of tumor multifocality, it would be unusual to identify tumors involving greater than one-half of 1 lobe (approximately an 8-cm3 tumor) without involving the other lobe. The authors question the existence of a true pT2b tumor.

KW - Classification

KW - Neoplasm

KW - Prostate

KW - Prostatectomy

KW - Tumor TNM staging

UR - http://www.scopus.com/inward/record.url?scp=2642544797&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=2642544797&partnerID=8YFLogxK

U2 - 10.1002/cncr.20305

DO - 10.1002/cncr.20305

M3 - Article

VL - 100

SP - 2573

EP - 2576

JO - Cancer

JF - Cancer

SN - 0008-543X

IS - 12

ER -